Pro Abtech
Latest round
- Series A
Last raised
- Oct 2021
Total raised
- $8.4M
Investors
- 6
About Pro Abtech
Founded in 2017 and based in Gwangju, South Korea, Pro Abtech operates as a biopharmaceutical development company that offers technology designed to overcome key limitations of improved biopharmaceutical drugs, including reduced activity, side effects, and low production yield..
Who invested in Pro Abtech
6 investors across 2 rounds
See all investors in Pro Abtech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pro Abtech
Who invested in Pro Abtech?
Pro Abtech has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pro Abtech raised?
Pro Abtech has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Pro Abtech last raise money?
Pro Abtech's most recent round on record is a Series A, in Oct 2021.
What does Pro Abtech do?
Founded in 2017 and based in Gwangju, South Korea, Pro Abtech operates as a biopharmaceutical development company that offers technology designed to overcome key limitations of improved biopharmaceutical drugs, including reduced activity, side effects, and low production yield.
Where is Pro Abtech headquartered?
Pro Abtech is headquartered in Gwangju, South Korea.
Which VCs invest in companies like Pro Abtech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Pro Abtech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Pro Abtech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.